FDA label
What is Quviviq used for?
Quviviq contains daridorexant. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “QUVIVIQ is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Quviviq?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Quviviq, tablet, film coated
Indications and Usage, quoted from the label by Idorsia Pharmaceuticals Ltd (NDA214985). Cross-references to other label sections are left out.
QUVIVIQ is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.
Source: DailyMed label, set id 3a2d1503-b816-40c9-9fac-7e03c5a3bcef, version 13, effective February 26, 2026. NDC 80491-7825, one of 2 listings for this product.
Questions
What is Quviviq used for?
The FDA label says: “QUVIVIQ is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.”
What drug class is Quviviq?
FDA lists daridorexant in the Orexin Receptor Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.